XSHE
301009
Market cap365mUSD
Oct 09, Last price
9.26CNY
1D
0.87%
1Q
11.30%
IPO
-64.71%
Name
Hangzhou Coco Healthcare Products Co Ltd
Chart & performance
P/E
68.31
P/S
2.14
EPS
0.14
Div yield, %
0.76%
Shrs. gr., 5y
1.99%
Rev. gr., 5y
-0.62%
Revenues
1.15b
+6.65%
Net income
36m
+15.87%
CFO
127m
+141.71%
Dividend
Jun 25, 20260.12 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hangzhou Coco Healthcare Products Co.,Ltd. is a Chinese enterprise dedicated to the innovation, manufacturing, and distribution of products across three main categories: baby care, adult incontinence, and pet hygiene. Its extensive portfolio of adult incontinence solutions features items such as adult diapers, pull-up pants, nursing pads, maternity towels, and menstrual pants, alongside a variety of general absorbent towels and specialized absorbent pads for men. Established in 2001, the company was initially known as Hangzhou Qiaozi Paper Industry Co.,Ltd. before adopting its current name, Hangzhou Coco Healthcare Products Co.,Ltd., in December 2011. Its operations are based in Hangzhou, China.
Key people
Chaonan Li
Chief Financial Officer, Deputy General Manager · since 2024
Liwei Jin
Executive Chairman of the Board, General Manager · since 2026
Zhongqi Wang
Deputy General Manager · since 2015
Jia Bao
Director · since 2024
Yanchuan Cheng
Director · since 2011
Shaonan Ren
Staff Elected Director · since 2026
Zhongying Zhou
Deputy General Manager, Director · since 2024
Naiquan Jing
Independent Director · since 2024
Hong Shou
Independent Director · since 2022
Weilin Xiao
Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||